COMBINATION THERAPY COMPRISING A TOR KINASE INHIBITOR AND N-(3-(5-FLUORO-2-(4-(2-METHOXYETHYOXY)PHENYLAMINO)PYRIMIDIN-4-YLAMINO)PHENYL)ACRYLAMIDE FOR TREATING CANCER
An effective amount of a TOR kinase inhibitor and an effective amount of an effective amount of a TOR kinase inhibitor of N- (3- (5-fluoro-2- (4- (2-methoxyethoxy) phenylamino) pyrimidin- Lt; RTI ID = 0.0 >; cancer, <; / RTI >;유효량의 TOR 키나제 억제제 및 N-(3-(5-플루오로-2-(4-(2-메톡시에톡시)페닐아미노)피리미딘-4-일아미노)페닐)아크릴아미드를 암 환자에게 투여하는 것을 포함하는 암의 치료 또는 예방 방법이 본원에 제공된다.